1st Medical Department Charles University General Hospital Prague Czech Republic

1st Medical Department Charles University General Hospital Prague Czech Republic Institute of Pathological Physiology 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Hemato Oncology Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc Olomouc Czech Republic

Department of Hematology and Oncology Masaryk University Hospital Brno Czech Republic

Department of Internal Medicine and Haematology Faculty Hospital Kralovske Vinohrady and 3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Pathology and Molecular Medicine 2nd Faculty of Medicine Charles University Hospital Motol Czech Republic

Department of Pathology Charles University Medical Faculty Plzen Prague Czech Republic

Institute of Pathology Charles University General Hospital Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc19045116

003      

CZ-PrNML

005      

20200113081735.0

007      

ta

008      

200109s2019 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1002/ajh.25362 $2 doi

035    __

$a (PubMed)30474171

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Klener, Pavel $u First Medical Department, Charles University General Hospital, Prague, Czech Republic. Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.

245    10

$a Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation / $c P. Klener, D. Salek, R. Pytlik, H. Mocikova, K. Forsterova, P. Blahovcova, V. Campr, V. Prochazka, A. Obr, R. Jaksa, J. Kuntscherova, L. Boudová, R. Kodet, A. Janikova, M. Trneny,

650    _2

$a dospělí $7 D000328

650    _2

$a senioři $7 D000368

650    _2

$a protokoly antitumorózní kombinované chemoterapie $x terapeutické užití $7 D000971

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a transplantace hematopoetických kmenových buněk $7 D018380

650    _2

$a lidé $7 D006801

650    _2

$a lymfom z plášťových buněk $x mortalita $x terapie $7 D020522

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    _2

$a doba přežití bez progrese choroby $7 D000077982

650    _2

$a indukce remise $x metody $7 D012074

650    _2

$a rituximab $x terapeutické užití $7 D000069283

650    _2

$a analýza přežití $7 D016019

650    _2

$a autologní transplantace $7 D014182

655    _2

$a klinické zkoušky $7 D016430

655    _2

$a dopisy $7 D016422

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Salek, David $u Department of Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic.

700    1_

$a Pytlik, Robert $u First Medical Department, Charles University General Hospital, Prague, Czech Republic.

700    1_

$a Mocikova, Heidi $u Department of Internal Medicine and Haematology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.

700    1_

$a Forsterova, Kristina $u First Medical Department, Charles University General Hospital, Prague, Czech Republic.

700    1_

$a Blahovcova, Petra $u First Medical Department, Charles University General Hospital, Prague, Czech Republic.

700    1_

$a Campr, Vit $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University Hospital, Motol, Czech Republic.

700    1_

$a Prochazka, Vit $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.

700    1_

$a Obr, Ales $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.

700    1_

$a Jaksa, Radek $u Institute of Pathology, Charles University General Hospital, Prague, Czech Republic.

700    1_

$a Kuntscherova, Jana $u Department of Pathology, Charles University Medical Faculty Plzen, Prague, Czech Republic.

700    1_

$a Boudová, Ludmila $u Department of Pathology, Charles University Medical Faculty Plzen, Prague, Czech Republic.

700    1_

$a Kodet, Roman $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University Hospital, Motol, Czech Republic.

700    1_

$a Janikova, Andrea $u Department of Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic.

700    1_

$a Trneny, Marek $u First Medical Department, Charles University General Hospital, Prague, Czech Republic.

773    0_

$w MED00000251 $t American journal of hematology $x 1096-8652 $g Roč. 94, č. 2 (2019), s. E50-E53

856    41

$u https://pubmed.ncbi.nlm.nih.gov/30474171 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20200109 $b ABA008

991    __

$a 20200113082107 $b ABA008

999    __

$a ok $b bmc $g 1483385 $s 1083789

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2019 $b 94 $c 2 $d E50-E53 $e 20181213 $i 1096-8652 $m American journal of hematology $n Am J Hematol $x MED00000251

GRA    __

$a PROGRES Q28/LF1 $p Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations $2 International

GRA    __

$a PROGRES Q26/LF1 $p Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations $2 International

GRA    __

$a UNCE/MED/016 $p Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations $2 International

GRA    __

$a AZV 17-28980A $p Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations $2 International

GRA    __

$p Charles University Center of Excellence $2 International

GRA    __

$p Ministry of Health of the Czech Republic $2 International

GRA    __

$a NV17-28980A $p MZ0

LZP    __

$a Pubmed-20200109